Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Assets Average (2016 - 2025)

Historic Assets Average for Pharma-Bio Serv (PBSV) over the last 15 years, with Q4 2025 value amounting to $13.6 million.

  • Pharma-Bio Serv's Assets Average fell 1647.35% to $13.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $13.6 million, marking a year-over-year decrease of 1647.35%. This contributed to the annual value of $15.0 million for FY2025, which is 1726.52% down from last year.
  • As of Q4 2025, Pharma-Bio Serv's Assets Average stood at $13.6 million, which was down 1647.35% from $13.7 million recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Assets Average ranged from a high of $30.1 million in Q1 2021 and a low of $13.6 million during Q4 2025
  • Its 5-year average for Assets Average is $20.5 million, with a median of $20.2 million in 2022.
  • In the last 5 years, Pharma-Bio Serv's Assets Average soared by 1387.38% in 2021 and then tumbled by 2832.81% in 2022.
  • Quarter analysis of 5 years shows Pharma-Bio Serv's Assets Average stood at $26.3 million in 2021, then dropped by 21.97% to $20.5 million in 2022, then fell by 1.91% to $20.1 million in 2023, then fell by 18.88% to $16.3 million in 2024, then dropped by 16.47% to $13.6 million in 2025.
  • Its Assets Average was $13.6 million in Q4 2025, compared to $13.7 million in Q3 2025 and $15.0 million in Q2 2025.